Search - tctmd.com

Displaying 81 - 100 of 168

Sort: Relevancy | Date

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

L.A. McKeown

September 05, 2019

News Daily News

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

Caitlin E. Cox

July 01, 2019

News Daily News

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

Todd Neale

June 17, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

L.A. McKeown

March 29, 2019

News Conference News ACC 2019

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Shelley Wood

March 11, 2019

News Daily News

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Michael O'Riordan

October 03, 2018

Presentation

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

October 03, 2018

Presentation TCT 2018

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Presenter: Philippe Genereux

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Presenter: Eric Van Belle

September 22, 2018

Presentation TCT 2018

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Presenter: Philippe Pibarot

September 22, 2018

Presentation TCT 2018

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

Presenter: Allan Schwartz

September 22, 2018

News Conference News PCR London Valves 2018

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Shelley Wood

September 12, 2018

News Conference News PCR London Valves 2018

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Shelley Wood

September 11, 2018

News Daily News

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

L.A. McKeown

August 20, 2018

Presentation ECHO 2018

The Role of Echo in the Management of Asymptomatic VHD

Presenter: Philippe Pibarot

April 18, 2018

News Daily News

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Yael L. Maxwell

March 01, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Daily News

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

L.A. McKeown

January 04, 2018

Presentation TCT 2017

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Presenter: Ariel Finkelstein, Ran Kornowski, Philippe Genereux

November 01, 2017

Advertisement

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

Life Expectancy Post-SAVR Varies by Age, Raising Questions for Treatment Timing

TCAR Use Growing for Carotid Stenosis as Positive Data Continue to Accumulate

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Survival Better With Early AVR for Severe Asymptomatic Aortic Stenosis, Says Retrospective Study

ACC 2019: A Smartwatch, Low-risk TAVR, and Bempedoic Acid Are Hoping for Luck Saint Paddy’s Day Weekend

Echo Parameters Identify At-Risk Asymptomatic Patients With Severe AS

Outcomes of Patients with Asymptomatic Aortic Stenosis (AS) Followed Up in Heart Valve Clinics

Putting It All Together: A Proposed New Staging Classification for Patients with Aortic Stenosis

Who Should be Treated? The Role of Biomarkers in Patient Selection and Procedure Optimization

Who Should be Treated? The Role of Imaging Guidance in Patient Selection

Rationale for Treating SASS and Update of the EARLY-TAVR Trial

No Symptoms? Some AS Patients Undergo Valve Replacement Despite Lack of Clinical Indication

Ten-Year Trends in the UK Show TAVR Rates Rising but SAVR Holding Steady

Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS

The Role of Echo in the Management of Asymptomatic VHD

LV Diastolic Dysfunction Linked With Higher Mortality Post-TAVR

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Registry Challenges LVEF Cutoff for AVR, With Implications for Asymptomatic Patients

TAVR in Asymptomatic Severe Aortic Stenosis: Updates From the EARLY TAVR Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content